Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Hepatology
- Vol. 7 (3) , 593-9
Abstract
Oxidative stress has been investigated in the context of alcoholic liver injury for many years and shown to be a causal factor of chronic hepatitis C (CHC), nonalcoholic steatohepatitis (NASH), drug-induced liver injury, Wilson's disease, and hemochromatosis. In CHC, it has been demonstrated that oxidative stress plays an important role in hepatocarcinogenesis. In cases with persistent hepatitis due to failure of hepatitis C virus eradication, or chronic liver disease, such as NASH, the treatment of which remains unestablished, it is important to reduce serum alanine aminotransferase levels and prevent liver fibrosis and development of hepatocellular carcinoma. This also suggests the importance of antioxidant therapy. Among treatment options where it would be expected that anti-inflammatory activity plays a role in their confirmed efficacy for chronic hepatitis, iron depletion therapy, glycyrrhizin, ursodeoxycholic acid, Sho-Saiko-To, and vitamin E can all be considered antioxidant therapies. To date, however, the ability of these treatments to prevent cancer has been confirmed only in CHC. Nevertheless, anti-inflammatory and anti-fibrotic effects have been demonstrated in other liver diseases and these therapies may potentially be effective for cancer prevention.Keywords
This publication has 65 references indexed in Scilit:
- Phase II clinical trial of phlebotomy for non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2013
- Vitamins C and E: Beneficial effects from a mechanistic perspectiveFree Radical Biology and Medicine, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Hepatitis C Virus–Induced Reactive Oxygen Species Raise Hepatic Iron Level in Mice by Reducing Hepcidin TranscriptionGastroenterology, 2008
- Ursodeoxycholic Acid Protects Hepatocytes against Oxidative Injury via Induction of AntioxidantsBiochemical and Biophysical Research Communications, 1999
- Risk factors and prevention of hepatocellular carcinoma in HCV infectionDigestive Diseases and Sciences, 1996
- Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitisJournal of Hepatology, 1995
- Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trialJournal of Hepatology, 1993
- Immunomodulatory Effects of Ursodeoxycholic Acid on Immune ResponsesHepatology, 1992
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985